Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    9624195 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients
Condition: Kidney Trasplant
Intervention: Drug: Valganciclovir
2 Terminated
Has Results
A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression
Condition: Kidney Transplant Failure and Rejection
Interventions: Drug: Tacrolimus (TAC);   Drug: Sirolimus;   Drug: Alemtuzumab;   Drug: Mycophenolate mofetil (MMF)

Study has passed its completion date and status has not been verified in more than two years.